Use of monoclonal antibodies specific to the O-acetylated form of GD2 ganglioside for the treatment of certain cancers

Details for Australian Patent Application No. 2007306384 (hide)

Owner Universite de Nantes

Inventors Supiot, Stephane; Chatal, JeanFrancois; Birkle, Stephane; Aubry, Jacques; Mussini, Jean-Marie; Barbet, Jacques

Agent Spruson & Ferguson

Pub. Number AU-B-2007306384

PCT Pub. Number WO2008/043777

Priority 0608881 10.10.06 FR

Filing date 10 October 2007

Wipo publication date 17 April 2008

Acceptance publication date 12 April 2012

International Classifications

C07K 16/30 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61P 35/00 (2006.01) Antineoplastic agents

C12N 15/13 (2006.01) Mutation or genetic engineering - Immunoglobulins

C12N 15/63 (2006.01) Mutation or genetic engineering - Introduction of foreign genetic material using vectors

C12P 21/08 (2006.01) Preparation of peptides or proteins - Monoclonal antibodies

G01N 33/574 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for cancer

G01N 33/577 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving monoclonal antibodies

Event Publications

4 June 2009 PCT application entered the National Phase

  PCT publication WO2008/043777 Priority application(s): WO2008/043777

29 October 2009 Amendment Made

  The nature of the amendment is: Add the names of co-inventors Mezazigh Hami, Assia and Supiot, Stephane

16 February 2012 Amendment Made

  The nature of the amendment is: Amend the name of the inventor to read Supiot, Stephane; Chatal, Jean-Francois; Birkle, Stephane; Aubry, Jacques; Mussini, Jean-Marie and Barbet, Jacques 2007356192 LG Electronics, Inc. The nature of the amendment is as shown in the statement(s) filed 09 Aug 2011 2008

12 April 2012 Application Accepted

  Published as AU-B-2007306384

28 June 2012 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 08 Jun 2012 . Address for service in Australia - Spruson & Ferguson Level 35 St Martins Tower 31 Market Street Sydney NSW 2000 2008

25 October 2012 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 08 Jun 2012 2008

1 November 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007306399-Vinylogous acids derivatives as chymase inhibitors

2007306382-Substituted pyrazinone derivatives for use as a medicine